Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 3 , Pages 196-198 , Autumn 2009

Coronary Revascularization—2009: State of the Art

  • David P. Taggart, MD, PhD, FRCS

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David P. Taggart, MD, PhD, FRCS, John Radcliffe Hospital, Oxford Heart Centre, Oxford OX3 9DU, UK

References 

  1. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563–570
  2. Taggart DP, Thomas BF. Lecture (Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know). Ann Thorac Surg. 2006;82:1966–1975
  3. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293–1304
  4. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147:703–716
  5. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomized trials. Lancet. 2009;(in press)
  6. Taggart DP. Surgery is the best intervention for severe coronary artery disease. BMJ. 2005;330:785–786
  7. Taggart DP. Percutaneous or surgical intervention in coronary artery disease. Lancet. 2009;(in press)
  8. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290–2295
  9. Hannan EL, Racz MJ. Walford get al Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174–2183
  10. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Northern New England Cardiovascular Disease Study Group Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: Analysis of Bari-like patients in northern New England. Circulation. 2005;112(suppl):I371–I376
  11. Smith PK, Califf RM, Tuttle RH, et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg. 2006;82:1420–1428
  12. Bair TL, Muhlestein JB, May HT, et al. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: Results from the intermountain Heart Registry. Circulation. 2007;116(suppl):I226–I231
  13. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331–341
  14. Niles NW, McGrath PD, Malenka D, et al. Northern New England Cardiovascular Disease Study Group Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: Results of a large regional prospective study (Northern New England Cardiovascular Disease Study Group). J Am Coll Cardiol. 2001;37:1008–1015
  15. Pell JP, Pell AC, Jeffrey RR, et al. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: Retrospective cohort study of 6320 procedures. Diabet Med. 2004;21:790–792
  16. BARI Investigators. The final 10-year follow-up results from the Bari randomized trial. J Am Coll Cardiol. 2007;49:1600–1606
  17. Serruys PW, Morice MC, Kappetein AP, et al. The SYNTAX Investigators (Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease). N Engl J Med. 2009;360:961–972
  18. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: A systematic review of studies comparing bilateral and single internal mammary arteries. Lancet. 2001;358:870–875
  19. Hannan EL, Wu C, Smith CR, et al. Off-pump versus on-pump coronary artery bypass graft surgery: Differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007;116:1145–1152
  20. Puskas JD, Edwards FH, Pappas PA, et al. Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. Ann Thorac Surg. 2007;84:1447–1454
  21. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406–2412
  22. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents (A hierarchical Bayesian meta-analysis). Ann Intern Med. 2003;138:777–786
  23. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet. 2007;370:937–948
  24. Hill R, Bagust A, Bakhai A, et al. Coronary artery stents: A rapid systematic review and economic evaluation. Health Technol Assess. 2004;8:1–242
  25. Griffin SC, Barber JA, Manca A, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: Prospective observational study. BMJ. 2007;334:624–627

 Dr. Taggart has received speaking fees and is an advisor to Medtronic.

PII: S1043-0679(09)00087-2

doi: 10.1053/j.semtcvs.2009.08.003

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 3 , Pages 196-198 , Autumn 2009

Article Tools